Expanding Patient Pools while Navigating Regulatory Landscapes in the European Market

The European clinical research landscape is quickly transforming. New regulatory initiatives, new technology, and new approaches to conducting research are all paving the way for a new era of clinical trials.

Yet one thing hasn't changed: the integrity of studies relies on the capacity to identify and enroll patients with a specific profile at dedicated clinical trial sites. As a sponsor, how do you adapt while ensuring you meet your bottom line?

Join Morgan Sellars and Steve Novak who will take a closer look at delivering impactful patient recruitment strategies which:

• Expand site access to patient pools outside of their existing networks
• Effectively navigate differing countries regulatory and cultural frameworks
• Improve the speed and precision of patient enrollment

Their discussion will highlight a study struggling to recruit rare disease patients in Germany during the height of the COVID-19 pandemic and the tactics used to:

• Enhance trial awareness among 57,000+ Health Care Providers (HCPs)
• Reach and enroll 3 of the less than 20 known patients diagnosed with the rare genetic disease in Germany at the time of recruitment
• ...and more!

The webinar is a joined initiative from BIO Deutschland’s working group for Regulatory affairs and Pharma Intelligence.

Further information: https://pages.pharmaintelligence.informa.com